Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Ataxia Telangiectasia and BRCA2[original query] |
---|
Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families. Breast cancer research : BCR 2004 6 (4): R401-7. Lindeman Geoffrey J, Hiew Melody, Visvader Jane E, Leary Jennifer, Field Michael, Gaff Clara L, Gardner R J McKinlay, Trainor Kevin, Cheetham Glenice, Suthers Graeme, Kirk Ju |
Mutation analysis of the ATR gene in breast and ovarian cancer families. Breast cancer research : BCR 2005 7 (4): R495-501. Heikkinen Katri, Mansikka Virpi, Karppinen Sanna-Maria, Rapakko Katrin, Winqvist Robe |
Does tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11?: considerations from somatic mutations in microsatellite unstable (MSI) gastrointestinal cancers. BMC genetics 2006 1 7 3. van der Heijden Michiel S, Brody Jonathan R, Elghalbzouri-Maghrani Elhaam, Zdzienicka Malgorzata Z, Kern Scott |
Screening for ATM sequence alterations in African-American women diagnosed with breast cancer. Breast cancer research and treatment 2008 Jan 107 (1): 139-44. Hirsch Ariel E, Atencio David P, Rosenstein Barry |
ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations. Clinical genetics 2008 May 73 (5): 465-73. Brunet J, Gutiérrez-Enríquez S, Torres A, Bérez V, Sanjosé S, Galceran J, Izquierdo A, Menéndez J A, Gumà J, Borràs |
Rare variants in the ATM gene and risk of breast cancer. Breast cancer research : BCR 2011 13 (4): R73. Goldgar David E, Healey Sue, Dowty James G, Da Silva Leonard, Chen Xiaoqing, Spurdle Amanda B, Terry Mary Beth, Daly Mary J, Buys Saundra M, Southey Melissa C, Andrulis Irene, John Esther M, , , Khanna Kum Kum, Hopper John L, Oefner Peter J, Lakhani Sunil, Chenevix-Trench Georg |
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry. Breast cancer research and treatment 2011 Jul 128 (2): 573-9. Graña B, Fachal L, Darder E, Balmaña J, Ramón Y Cajal T, Blanco I, Torres A, Lázaro C, Diez O, Alonso C, Santamariña M, Velasco A, Teulé A, Lasa A, Blanco A, Izquierdo A, Borràs J, Gutiérrez-Enríquez S, Vega A, Brunet |
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer 2017 1 123 (10): 1721-1730. Buys Saundra S, Sandbach John F, Gammon Amanda, Patel Gayle, Kidd John, Brown Krystal L, Sharma Lavania, Saam Jennifer, Lancaster Johnathan, Daly Mary |
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
Olaparib and celarasertib (AZD6738) in patients with triple negative advanced breast cancer: results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Alistair Ring, Lucy S Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr, Andrew M Wardley, Bora Gurel, Iain R Macpherson, Ruth Riisnaes, Richard D Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C Winter, Kathryn Dunne, Ellen Copson, Tamas Hickish, Russell Burcombe, Kat Randle, Violeta Serra, Alba Llop-Guevara, Judith M Bliss, Nicholas C Turn |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: